94 results
PRE 14A
PRME
Prime Medicine Inc
19 Apr 24
Preliminary proxy
4:07pm
believe best represent our Company values and can make significant contributions towards achieving our purpose of delivering a new class of differentiated … one-time curative genetic therapies to address the widest spectrum of diseases by deploying our Prime Editing technology. Our program’s purpose
S-8
PRME
Prime Medicine Inc
1 Mar 24
Registration of securities for employees
8:09am
in an increase in the number of the Registrant’s outstanding shares of Common Stock.
Estimated solely for the purpose of calculating the registration
S-8
PRME
Prime Medicine Inc
1 Mar 24
Registration of securities for employees
8:09am
This Registration Statement on Form S-8 (this “Registration Statement”) is being filed for the purpose of registering an additional 4,868,856 shares of common
8-K
EX-1.1
f1sns 2mjqz4w
16 Feb 24
Entry into a Material Definitive Agreement
6:23am
8-K
EX-4.1
dop n2fpx99
16 Feb 24
Entry into a Material Definitive Agreement
6:23am
424B5
dvhsm1
16 Feb 24
Prospectus supplement for primary offering
6:17am
424B5
pu5vdybq23allh7us
14 Feb 24
Prospectus supplement for primary offering
5:27pm
8-K
EX-10.1
fmuwf
5 Jan 24
Departure of Directors or Certain Officers
8:15am
S-3
EX-1.2
x9v5331
3 Nov 23
Shelf registration
5:23pm
S-3
EX-4.6
yzsurf09
3 Nov 23
Shelf registration
5:23pm
S-3
EX-4.5
540qzmkga bf
3 Nov 23
Shelf registration
5:23pm
S-3
e0ypf83tqhymzpzu96z0
3 Nov 23
Shelf registration
5:23pm
DEF 14A
hs5 gji2snyrq
28 Apr 23
Definitive proxy
8:34am
10-Q
uvmuktvc13 ppwcu4xf
14 Nov 22
Quarterly report
4:46pm
8-K
EX-3.2
h51fo2 sr8r8
24 Oct 22
Amendments to Articles of Incorporation or Bylaws
4:41pm